Abstract
Many autoimmune diseases were reported as a sequel of SARS CoV-2 infection. We report here a 51-year-old female who presented with myalgia, progressive quadriparesis, and skin rash 2 weeks after COVID-19 infection. She improved with high-dose methylprednisolone. She was given oral methotrexate and mycophenolic acid during follow up. However, her condition deteriorated until she passed away half a year after the initial illness. This case showed that dermatomyositis can be associated with COVID-19 infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have